Research Article
Seroprevalence of Herpes Simplex Virus Infection in HIV Coinfected Individuals in Eastern India with Risk Factor Analysis
Table 4
Seroprevalence of HSV-1 and 2 antibodies (IgM and IgG) in different study groups.
| | | HIV patient group | HIV control group | Non-HIV control group | Total | Chi square test
( value) | | R | NR | T | R | NR | T | R | NR | T | R | NR | T |
| HSV1
IgM | 2 (3.8%) | 50 (96.2%) | 52 (100%) | 2 (4.4%) | 43 (95.6%) | 45 (100%) | 1 (2.2%) | 44 (97.8%) | 45 (100%) | 5 (3.5%) | 137 (96.5%) | 142 (100%) | 0.838 (not statistically significant) | HSV1
IgG | 49 (94.2%) | 3 (5.8%) | 52 (100%) | 42 (93.3%) | 3 (6.7%) | 45 (100%) | 40 (88.9%) | 5 (11.1%) | 45 (100%) | 131 (92.3%) | 11 (7.7%) | 142 (100%) | 0.585 (not statistically significant) | HSV2
IgM | 18 (34.6%) | 34 (65.4%) | 52 (100%) | 1 (2.2%) | 44 (97.8%) | 45 (100%) | 1 (2.2%) | 44 (97.8%) | 45 (100%) | 20 (14.1%) | 122 (85.9%) | 142 (100%) | 0.000
(statistically significant) | HSV2
IgG | 32 (61.5%) | 20 (38.5%) | 52 (100%) | 26 (57.8%) | 19 (42.2%) | 45 (100%) | 8 (17.78%) | 37 (82.22%) | 45 (100%) | 66 (46.48%) | 76 (53.52%) | 142 (100%) | 0.000 (statistically significant) |
|
|
